Home / World Marketplace / Archive by category Global Health & Biotech (Page 4)

Archive by category Global Health & Biotech

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted positive opinions for two Boehringer poultry vaccines against the highly pathogenic H5 avian influenza virus1. VAXXITEK® HVT+IBD+H5 is the first trivalent vaccine offering combined protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in chickens and turkeys in one single [...]

New Global Study: Dangerous Nighttime Heat Rising in 83% of Global Cities Analyzed, Becoming More Oppressive, And More Frequent

WASHINGTON, Nov. 19, 2025 (Korea Bizwire) – While leaders have been focusing on avoiding breaching the +1.5°C threshold of the Paris Agreement, a sweeping new scientific analysis of the most dangerous summer weather conditions across 100 major global cities revealed that minimum nighttime temperatures have been rising up to 10 times faster than daytime average [...]

Asia Front and Centre: CAPHRA Powers Regional Voice at GoodCOP 2.0

GENEVA, Nov. 20, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is celebrating the successful “Asia Day” event at the GoodCOP 2.0 held in Geneva. The event, held during the same week as the FCTC COP11 brought together consumer advocates, public health experts, medical professionals, and policymakers to highlight [...]

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs Teva’s first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth Strategy Rise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact [...]

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

VANCOUVER, British Columbia, Nov. 18, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer. Mr. Platshon will report directly to Zymeworks’ Chair and Chief Executive Officer, Kenneth [...]

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholders Strategic initiative follows positive topline results from pivotal Phase 3 HERIZON-GEA-01 trial evaluating zanidatamab in first-line gastroesophageal adenocarcinoma (GEA) and pasritamig advancing to registration studies by J&J Innovative Medicine (J&J) Eligible to receive up to $440.0 million in potential [...]

Philips brings AI into the procedure room to assist doctors during heart valve repair

November 17, 2025 Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence** Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one [...]

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Biopharma will continue to lead discovery and new product development Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium International headquarters remain in Paris, France, while the United States headquarters are in St Louis, Missouri ST. LOUIS, Nov. 17, 2025 (Korea Bizwire) – Curium, a company dedicated [...]

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal

Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim analysis Ziihera plus Tevimbra® (tislelizumab) and chemotherapy demonstrated clinically meaningful and statistically significant improvements in OS and PFS versus trastuzumab and [...]

Positioning Barbados as the Caribbean’s Life Sciences Hub

EarlyHealth City to Anchor US$200 Million Investment BRIDGETOWN, Barbados, Nov. 14, 2025 (Korea Bizwire) – Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world-class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church. The [...]